{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:07:06Z","timestamp":1788246426178,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Research question<\/jats:title><jats:p>Do embryo parameters and live birth rates differ between patients with endometrioma undergoing a freeze-all strategy using either GnRH antagonists or progestin-primed ovarian stimulation (PPOS)?<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>This retrospective cohort study was conducted at Bahceci Health Group from January 2021 to January 2023. Inclusion criteria were females aged 20\u201340 with confirmed endometriosis, using either GnRH antagonists or PPOS ovarian stimulation, and opting for freezing all embryos without fresh embryo transfer (ET). A total of 543 patients were analyzed, with the primary outcome being usable embryos at cleavage stage and secondary outcomes including distribution of embryo quality, clinical pregnancy, and live birth rate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For the GnRH antagonist arm, the median (25th-75th percentiles) total gonadotropin dose required during stimulation was significantly higher (2725 [2100\u20133587.5] vs. 2400 [2050\u20133075] IU, p = 0.001) and duration was longer (11 [10\u201312] vs. 10 [9\u201311] days, p = 0.01), although number of mature oocytes and maturation and fertilization rates were similar in both arms. However, the linear regression analysis revealed that the number of usable day-three embryos was higher with the PPOS protocol than with the GnRH antagonist protocol (OR: 0.890, CI 95%: 0.226 \u2013 1.554, p= 0.009). Particularly in patients that had undergone FET, the respective live birth rates were 50.0% and 54.6% in GnRH antagonist and PPOS arms, respectively, without any statistical significance (p= 0.365).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In patients with endometrioma, the PPOS protocol over GnRH antagonists might potentially enhance the quantity of usable cleavage-stage embryos while showing no significant impact on the number of collected oocytes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1492293","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:10:49Z","timestamp":1751947849000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A comparative analysis of progestin-primed ovarian stimulation versus GnRH antagonists protocols pertaining to stimulation parameters and embryological outcomes in patients with endometrioma"],"prefix":"10.3389","volume":"16","author":[{"given":"Fazilet Kubra","family":"Boynukalin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Ayta\u00e7","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Gultomruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zalihe","family":"Yarkiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren Melisa","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Ozkavukcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Bahceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcrkan","family":"Bozda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum Reprod Open"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv035","article-title":"The impact of endometrioma on IVF\/ICSI outcomes: a systematic review and meta-analysis","volume":"21","author":"Hamdan","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/AOG.0000000000000592","article-title":"Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis","volume":"125","author":"Hamdan","year":"2015","journal-title":"Obstet Gynecol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12366","article-title":"The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis","volume":"120","author":"Harb","year":"2013","journal-title":"BJOG"},{"key":"B5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12958-023-01157-8","article-title":"Endometriosis and IVF treatment outcomes: unpacking the process","volume":"21","author":"Somigliana","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.03.015","article-title":"Endometrioma-related reduction in ovarian reserve: a prospective longitudinal study","volume":"110","author":"Kasapoglu","year":"2018","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del231","article-title":"Measuring quality of life in women with endometriosis","volume":"21","author":"Jones","year":"2006","journal-title":"Hum Reprod"},{"key":"B8","doi-asserted-by":"publisher","first-page":"20420188231173325","DOI":"10.1177\/20420188231173325","article-title":"Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review","volume":"14","author":"Kuan","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13048-020-00622-x","article-title":"Live birth rate comparison of three controlled ovarian stimulation protocols for IVF-ET in patients with diminished ovarian reserve","volume":"13","author":"Zhao","year":"2020","journal-title":"J Ovarian Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.6.8526","article-title":"Long-term progestin treatment inhibits RANTES gene expression","volume":"87","author":"Zhao","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02460-w","article-title":"Association of embryo transfer type with infertility in endometriosis: a systematic review and meta-analysis","volume":"39","author":"Chang","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der037","article-title":"Alpha Scientists in Reproductive Medicine, ESHRE SIG of Embryology. The Istanbul consensus workshop on embryo assessment","volume":"26","year":"2011","journal-title":"Hum Reprod"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-199906000-00013","article-title":"Culture and transfer of human blastocysts","volume":"11","author":"Gardner","year":"1999","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2023.102429","article-title":"IVF stimulation protocols and outcomes in women with endometriosis","volume":"92","author":"Goyri","year":"2024","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate as oral alternative in IVF","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.581927","article-title":"PPOS improves IVF outcomes in fertility-preserved endometrial pathology","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.02.036","article-title":"MPA as alternative to GnRH antagonist in oocyte donation","volume":"116","author":"Giles","year":"2021","journal-title":"Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression in ART: systematic review","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.06.012","article-title":"Comparison of cumulative live birth after IVF using antagonist vs. PPOS protocol","volume":"118","author":"Chen","year":"2022","journal-title":"Fertil Steril"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-023-07269-1","article-title":"GnRH antagonist vs. PPOS in PCOS: systematic review","volume":"309","author":"Deng","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/14647273.2024.2316005","article-title":"Cumulative live birth in IVF with PPOS vs. antagonist: RCT","volume":"27","author":"Ye","year":"2024","journal-title":"Hum Fertil"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det050","article-title":"World Endometriosis Society. Consensus on current management of endometriosis","volume":"28","author":"Johnson","year":"2013","journal-title":"Hum Reprod"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmg030","article-title":"Progestogens for endometriosis","volume":"9","author":"Vercellini","year":"2003","journal-title":"Hum Reprod Update"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11927","DOI":"10.1038\/s41598-017-12151-7","article-title":"MPA in ovarian endometriosis IVF stimulation","volume":"7","author":"Guo","year":"2017","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1038\/s41598-023-32797-w","article-title":"Metabolomics of follicular fluid in PPOS protocol for endometriosis","volume":"13","author":"Guo","year":"2023","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.798434","article-title":"PPOS protocol for endometrioma","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.2022334","article-title":"Factors in DIE, adenomyosis, and endometrioma","volume":"52","author":"Yuan","year":"2023","journal-title":"Ann Acad Med Singap"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-021-00818-6","article-title":"Uterine adenomyosis and IVF outcomes","volume":"29","author":"Cozzolino","year":"2022","journal-title":"Reprod Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077025","article-title":"IVF\/ICSI outcomes in adenomyosis: systematic review","volume":"14","author":"Ge","year":"2024","journal-title":"BMJ Open"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1492293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:10:49Z","timestamp":1751947849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1492293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":29,"alternative-id":["10.3389\/fendo.2025.1492293"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1492293","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"article-number":"1492293"}}